The future will see more pharma companies leveraging AI to improve diversity and inclusion, especially in trials that are diverse by design, as well as the odds of finding patients who fit an acceptable set of inclusion/exclusion criteria to accelerate clinical trial timelines. The post A Bright Future for AI in Pharma appeared first on…
We are on the cusp of being held accountable not just for what we did wrong, but for what we failed to do, especially when readily available, life-saving technology could have made a difference. The post When Inaction Becomes Negligence in the Age of AI appeared first on MedCity News.
Former President Donald Trump and Vice President Kamala Harris have a rare point of agreement in their otherwise bitter and divisive contest: It’s up to the government to cut high U.S. drug prices. Harris cast the tie-breaking Senate vote in 2022 for legislation that allows Medicare to negotiate drug prices for its more than 60…
By involving highly experienced therapists and mental health administration experts from the beginning of development of new tech, we not only build tools that are more effective, but also build trust and confidence among clinicians. The post The Missing Piece: Tech and Mental Health appeared first on MedCity News.
By KIM BELLARD In 2025, we’ve got DNA all figured out, right? It’s been over fifty years since Crick and Watson (and Franklin) discovered the double helix structure. We know that permutations of just four chemical bases (A, C, T, and G) allow the vast genetic complexity and diversity in the world. We’ve done the…
Senators John Kennedy (R-Louisiana) and Eric Schmitt (R-Missouri) introduced a bill last week that would require “able-bodied adults” without dependents to work or volunteer for at least 20 hours per week to receive Medicaid benefits. The post Senators Introduce Bill that would Add Work Requirements for Medicaid appeared first on MedCity News.
Cardiovascular disease drugs in development intended to reduce lipoprotein (a) are mostly injectable medications, though Eli Lilly also has both oral and injectable drugs in the clinic. AstraZeneca aims to hit that key protein target with an oral small molecule licensed from CSPC Pharmaceutical Group. The post AstraZeneca Expands Cardiovascular Disease Prospects, Paying $100M for…
Digital health M&A, 340B challenges and federal funding cuts are top healthcare trends to watch in 2026, according to LRVHealth. The post One VC Firm’s 6 Predictions for the Future of Healthcare in 2026 appeared first on MedCity News.
How many companies will be left standing once consolidation hits the AI in healthcare sector? Which pharma companies are working with the Trump administration to lower costs? The post Debunked Episode 21: The Drug Price Debate, AI in Healthcare Companies Face Consolidation But How Much? appeared first on MedCity News.
A Chief AI Officer is a strategic necessity to help hospitals navigate the opportunities, challenges, and risks associated with applying AI innovation to improve patient care. The post Prioritizing AI in the C-Suite: Why Every Hospital Needs a CAIO appeared first on MedCity News.